|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Zafgen to Present at The Obesity Society 29th Annual Scientific Meeting
9/28/2011 10:02:58 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced that the company will be presenting at Obesity 2011, The Obesity Society’s 29th Annual Scientific Meeting, being held Oct. 1-5, 2011 at the Orlando World Center Marriott in Orlando, Fla. Zafgen will present a clinical update on beloranib and Phase 1b study highlights, as well as a poster for fumagillin, a prototype methionine aminopeptidase 2 (MetAP2) inhibitor.
|
|
|
|
|
|
|
|
|
|
|